[
  {
    "date": "2020-12-30",
    "symbol": "ACUR",
    "period": "FY",
    "documenttype": "10-K",
    "documentperiodenddate": "2020-12-31",
    "entityregistrantname": "ACURA PHARMACEUTICALS, INC",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "tradingsymbol": "ACUR",
    "entitycentralindexkey": 786947,
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 413000,
    "royaltyreceivable": 30000,
    "collaborationrevenuereceivable": 197000,
    "licensefeereceivablefromrelatedpartiescurrent": 400000,
    "prepaidexpenseandotherassetscurrent": 139000,
    "assetscurrent": 1179000,
    "propertyplantandequipmentnet": 484000,
    "finitelivedintangibleassetsnet": 73000,
    "assets": 1736000,
    "accountspayablecurrent": 31000,
    "accruedliabilitiescurrent": 631000,
    "shorttermborrowings": 164000,
    "otherliabilitiescurrent": 18000,
    "longtermdebtcurrent": 6000000,
    "interestpayablecurrentrelatedparty": 678000,
    "liabilitiescurrent": 7522000,
    "longtermdebtsecurednoncurrent": 105000,
    "liabilities": 7627000,
    "commonstockvalue": 216000,
    "additionalpaidincapitalcommonstock": 383097000,
    "retainedearningsaccumulateddeficit": -389204000,
    "stockholdersequity": -389204000,
    "liabilitiesandstockholdersequity": 1736000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 21650000,
    "commonstocksharesoutstanding": 21650000,
    "revenuefromroyalty": 102000,
    "othersalerevenuesnet": 238000,
    "revenuefromlicensefee": 3000000,
    "revenuefromproductsalesnetofallowance": 223000,
    "revenues": 3570000,
    "researchanddevelopmentexpense": 1781000,
    "sellinggeneralandadministrativeexpense": 2547000,
    "costsandexpenses": 4328000,
    "operatingincomeloss": -758000,
    "interestexpense": 450000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -1208000,
    "netincomeloss": -1208000,
    "earningspersharebasic": -0.04,
    "earningspersharediluted": -0.04,
    "weightedaveragenumberofsharesoutstandingbasic": 32320000,
    "weightedaveragenumberofdilutedsharesoutstanding": 32320000,
    "sharesoutstanding": 21650000,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": 3000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 350000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 36000,
    "depreciation": 56000,
    "sharebasedcompensation": 36000,
    "amortizationofintangibleassets": 69000,
    "impairmentofintangibleassetsfinitelived": 668000,
    "increasedecreaseinsalesreturnliability": 223000,
    "increasedecreaseinroyaltyreceivable": -52000,
    "increasedecreaseincollaborationrevenuereceivable": 119000,
    "increasedecreaseinlicensefeereceivablefromrelatedparties": 400000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 17000,
    "incometaxesrefundable": -68000,
    "increasedecreaseinaccountspayable": -206000,
    "increasedecreaseinaccruedliabilities": 46000,
    "increasedecreaseininterestpayabletorelatedparty": 449000,
    "increasedecreaseinothercurrentliabilities": 10000,
    "netcashprovidedbyusedinoperatingactivities": -719000,
    "proceedsfromdistributionofrestrictedstockunits": 3000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 2000,
    "proceedsfromshorttermdebt": 269000,
    "netcashprovidedbyusedinfinancingactivities": 270000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -449000,
    "workingcapital": 6600000,
    "debtinstrumentcarryingamount": 6000000,
    "allocatedsharebasedcompensationexpense": 53000,
    "propertyplantandequipmentusefullife": "P7Y",
    "longtermdebt": 7400000,
    "noncancelablearrangementsamountdevelopmentandscale": 75000,
    "finitelivedintangibleassetsgross": 2000000,
    "finitelivedintangibleassetsaccumulatedamortization": 1259000,
    "finitelivedintangibleassetsreserveforimpairment": 668000,
    "minimumnetsalesreachingdescription": "one-time $12.5 million sales-based milestone payment when worldwide Oxaydo net sales reach $150 million in a calendar year.",
    "debtconversionconvertedinstrumentwarrantsoroptionsissued1": 10000000,
    "finitelivedintangibleassetsexpectedamortizationexpenseperquarter": 6000,
    "contractbalanceandperformanceobligationsdescription": "The Company had no contract assets and contract liability balances under the license and collaboration agreements at either December 31, 2020 or 2019.",
    "propertyplantandequipmentgross": 70000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2025000,
    "accruedcostsharingexpenses": 428000,
    "otheraccruedliabilitiescurrent": 24000,
    "employeerelatedliabilitiescurrent": 8000,
    "accruedprofessionalfeescurrent": 117000,
    "financedinsurancepremiums": 28000,
    "accrualfortaxesotherthanincometaxescurrent": 9000,
    "otheraccruedtaxescurrent": 17000,
    "interestexpenserelatedparty": 450000,
    "interestexpensedebt": 450000,
    "interestpayablecurrent": 678000,
    "shareprice": 0.01,
    "warrantsnotsettleableincashfairvaluedisclosure": 495000,
    "proceedsfromissuanceofwarrants": 4000000,
    "revenuefromcontractwithcustomerincludingassessedtax": 9000,
    "maximumbasiccontributionpercentageperemployeeonannualearnings": 0.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 11782000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 60000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.09,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 2.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1254000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 839000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 219000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentotherthanoptionsdistributedinperiod": 397000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 219000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 13000,
    "sharebasedcompensationnonemployeeservicestransactioncashsettlementpercentage": 0.4,
    "deferredcompensationarrangementwithindividualrecordedliability": 18000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -254000,
    "incometaxreconciliationstateandlocalincometaxes": -76000,
    "incometaxreconciliationtaxcreditsresearch": 18000,
    "effectiveincometaxratereconciliationtaxcreditfederalresearchamount": 76000,
    "incometaxreconciliationotheradjustments": -120000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 544000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 2269000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 903000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1283000,
    "deferredtaxassetsstateresearchtaxcreditcarryforwards": 31000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 104000,
    "deferredtaxassetsdebtextinguishment": 636000,
    "deferredtaxassetsother": 301000,
    "deferredtaxassetsgross": 5527000,
    "deferredtaxassetsvaluationallowance": 5527000,
    "operatinglosscarryforwards": 138000000,
    "operatinglosscarryforwardsexpirationterm": "P20Y",
    "taxcreditcarryforwardamount": 150000,
    "weightedaveragenumberofsharesissuedbasic": 21650000,
    "weightedaveragenumberofsharesrestrictedstock": 670000,
    "weightedaveragenumberofshareswarrants": 10000000,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 32320000,
    "earningspersharebasicanddiluted": -0.04,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1782000
  },
  {
    "date": "2019-12-30",
    "symbol": "ACUR",
    "period": "FY",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "ACURA PHARMACEUTICALS, INC",
    "entitycentralindexkey": 786947,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "security12btitle": "Common Stock, $0.01 par value",
    "tradingsymbol": "ACUR",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "amendmentflag": "false",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 862000,
    "royaltyreceivable": 21000,
    "collaborationrevenuereceivable": 78000,
    "prepaidexpenseandotherassetscurrent": 122000,
    "incometaxesreceivable": 34000,
    "assetscurrent": 1178000,
    "incometaxesreceivablenoncurrent": 34000,
    "propertyplantandequipmentnet": 540000,
    "finitelivedintangibleassetsnet": 810000,
    "assets": 2562000,
    "accountspayablecurrent": 237000,
    "accruedliabilitiescurrent": 585000,
    "otherliabilitiescurrent": 29000,
    "salesreturnsliabilitycurrent": 223000,
    "liabilitiescurrent": 1074000,
    "longtermdebtnoncurrent": 6000000,
    "interestpayablenoncurrentrelatedparty": 229000,
    "liabilities": 7303000,
    "commonstockvalue": 213000,
    "additionalpaidincapitalcommonstock": 383042000,
    "retainedearningsaccumulateddeficit": -387996000,
    "stockholdersequity": -387996000,
    "liabilitiesandstockholdersequity": 2562000,
    "accumulatedamortizationdeferredfinancecosts": 1190000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 100000,
    "commonstocksharesissued": 21300,
    "commonstocksharesoutstanding": 21300,
    "revenuefromroyalty": 21000,
    "othersalerevenuesnet": 185000,
    "revenuefromlicensefee": 2100000,
    "revenues": 2657000,
    "researchanddevelopmentexpense": 1505000,
    "sellinggeneralandadministrativeexpense": 1877000,
    "costsandexpenses": 3382000,
    "operatingincomeloss": -725000,
    "gainslossesonextinguishmentofdebt": -2600000,
    "interestexpense": 449000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -3774000,
    "netincomeloss": -3774000,
    "earningspersharebasic": -0.14,
    "earningspersharediluted": -0.14,
    "weightedaveragenumberofsharesoutstandingbasic": 26720000,
    "weightedaveragenumberofdilutedsharesoutstanding": 26720000,
    "sharesoutstanding": 21300,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": 3000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 266,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 108000,
    "adjustmentstoadditionalpaidincapitaldebtpremiumfromdebtmodification": 1382000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 1145000,
    "depreciation": 66000,
    "sharebasedcompensation": 108000,
    "capitalizeddebtdiscount": 13000,
    "amortizationoffinancingcostsanddiscounts": 66000,
    "amortizationofintangibleassets": 207000,
    "gainlossondispositionofassets": -1000,
    "increasedecreaseinroyaltyreceivable": -55000,
    "increasedecreaseincollaborationrevenuereceivable": 78000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -44000,
    "increasedecreaseinincometaxesreceivable": -67000,
    "increasedecreaseinaccountspayable": -368000,
    "increasedecreaseinaccruedliabilities": -11000,
    "increasedecreaseininterestpayabletorelatedparty": 394000,
    "increasedecreaseinothercurrentliabilities": 18000,
    "netcashprovidedbyusedinoperatingactivities": -618000,
    "proceedsfromdistributionofrestrictedstockunits": 14000,
    "proceedsfromrelatedpartydebt": 1375000,
    "netcashprovidedbyusedinfinancingactivities": 1389000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 771000,
    "duetorelatedpartiescurrentandnoncurrent": 650000,
    "interestincomerelatedparty": 13000,
    "cashcashequivalentsandrefundabledeposits": 862000,
    "workingcapital": 104000,
    "allocatedsharebasedcompensationexpense": 13000,
    "propertyplantandequipmentusefullife": "P7Y",
    "debtconversionconvertedinstrumentwarrantsoroptionsissued1": 10000000,
    "shareprice": 0.01,
    "debtinstrumentcarryingamount": 6000000,
    "longtermdebt": 7400000,
    "licensereceivableterm": "P5Y",
    "noncancelablearrangementsamountdevelopmentandscale": 502000,
    "minimumnetsalesreachingdescription": "one-time $12.5 million sales-based milestone payment when worldwide Oxaydo net sales reach $150 million in a calendar year.",
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 207000,
    "contractbalanceandperformanceobligationsdescription": "The Company had no contract assets and contract liability balances under the license and collaboration agreements at either December 31, 2019 or 2018.",
    "propertyplantandequipmentgross": 70000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1969000,
    "accruedcostsharingexpenses": 363000,
    "otheraccruedliabilitiescurrent": 15000,
    "employeerelatedliabilitiescurrent": 13000,
    "accruedprofessionalfeescurrent": 151000,
    "accruedotherprofessionalfeescurrent": 20000,
    "accrualfortaxesotherthanincometaxescurrent": 9000,
    "otheraccruedtaxescurrent": 14000,
    "interestexpenserelatedparty": 392000,
    "interestexpensedebtdiscount": 66000,
    "debtrelatedcommitmentfeesanddebtissuancecosts": 231000,
    "interestexpensefinanceinsurancepolicy": 4000,
    "interestexpensedebt": 462000,
    "paymentsofdebtissuancecosts": 13000,
    "debtinstrumentfeeamount": 50000,
    "debtconsultingplacementfee": 100000,
    "debtinstrumentunamortizeddiscount": 400000,
    "classofwarrantorrightoutstanding": 60000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 2.52,
    "classofwarrantorrightexpirationdate": "December 27, 2020",
    "debtinstrumentperiodicpayment": 260000,
    "debtinstrumentinterestrateeffectivepercentage": 0.1016,
    "benefittointerestincome": 13000,
    "warrantsnotsettleableincashfairvaluedisclosure": 495000,
    "maximumbasiccontributionpercentageperemployeeonannualearnings": 0.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 11842000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 10000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 170000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.01,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 30.83,
    "classofwarrantorrightterm": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 34000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1356000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1017000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 333000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 825000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 9000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentotherthanoptionsdistributedinperiod": 267000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 20000,
    "sharebasedcompensationnonemployeeservicestransactioncashsettlementpercentage": 0.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 219000,
    "deferredcompensationarrangementwithindividualrecordedliability": 29000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -792000,
    "incometaxreconciliationstateandlocalincometaxes": -138000,
    "incometaxreconciliationtaxcreditsresearch": 2000,
    "effectiveincometaxratereconciliationtaxcreditfederalresearchamount": 23000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 4000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 951000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 2622000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 869000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1207000,
    "deferredtaxassetsstateresearchtaxcreditcarryforwards": 8000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 72000,
    "deferredtaxassetsother": 177000,
    "deferredtaxassetsgross": 4955000,
    "deferredtaxassetsvaluationallowance": 4955000,
    "operatinglosscarryforwards": 167800000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "operatinglosscarryforwardsexpirationterm": "P20Y",
    "taxcreditcarryforwardamount": 150000,
    "weightedaveragenumberofsharesissuedbasic": 21300000,
    "weightedaveragenumberofsharesrestrictedstock": 296000,
    "weightedaveragenumberofshareswarrants": 5124000,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 26720000,
    "earningspersharebasicanddiluted": -0.14,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1842000,
    "litigationsettlementexpense": 2000
  },
  {
    "date": "2018-12-30",
    "symbol": "ACUR",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2018-12-31",
    "documentfiscalyearfocus": 2018,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "ACURA PHARMACEUTICALS, INC",
    "entitycentralindexkey": 786947,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "security12btitle": "Common Stock, $0.01 par value",
    "tradingsymbol": "ACUR",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 91000,
    "royaltyreceivable": 24000,
    "prepaidexpenseandotherassetscurrent": 166000,
    "incometaxesreceivable": 67000,
    "assetscurrent": 461000,
    "incometaxesreceivablenoncurrent": 68000,
    "propertyplantandequipmentnet": 606000,
    "finitelivedintangibleassetsnet": 1017000,
    "assets": 2152000,
    "accountspayablecurrent": 605000,
    "accruedliabilitiescurrent": 596000,
    "otherliabilitiescurrent": 11000,
    "salesreturnsliabilitycurrent": 223000,
    "liabilitiescurrent": 1435000,
    "duetorelatedpartiesnoncurrent": 4224000,
    "interestpayablenoncurrentrelatedparty": 110000,
    "liabilities": 5769000,
    "commonstockvalue": 210000,
    "additionalpaidincapitalcommonstock": 380395000,
    "retainedearningsaccumulateddeficit": -384222000,
    "stockholdersequity": -384222000,
    "liabilitiesandstockholdersequity": 2152000,
    "accumulatedamortizationdeferredfinancecosts": 983000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 100000,
    "commonstocksharesissued": 21034,
    "commonstocksharesoutstanding": 20796,
    "revenuefromroyalty": 24000,
    "revenues": 410000,
    "researchanddevelopmentexpense": 1759000,
    "sellinggeneralandadministrativeexpense": 2566000,
    "costsandexpenses": 4325000,
    "operatingincomeloss": -3915000,
    "interestexpense": 223000,
    "gainslossesonextinguishmentofdebt": -167000,
    "nonoperatingincomeexpense": 73000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -3842000,
    "netincomeloss": -3842000,
    "earningspersharebasic": -0.18,
    "earningspersharediluted": -0.18,
    "weightedaveragenumberofsharesoutstandingbasic": 21146000,
    "weightedaveragenumberofdilutedsharesoutstanding": 21146000,
    "sharesoutstanding": 21034,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 218000,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": 2000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 238,
    "depreciation": 73000,
    "sharebasedcompensation": 218000,
    "capitalizeddebtdiscount": 172000,
    "amortizationoffinancingcostsanddiscounts": 87000,
    "amortizationofintangibleassets": 207000,
    "increasedecreaseinroyaltyreceivable": 66000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -109000,
    "increasedecreaseinaccountspayable": 602000,
    "increasedecreaseinaccruedliabilities": -343000,
    "increasedecreaseininterestpayablenet": -566000,
    "increasedecreaseininterestpayabletorelatedparty": 110000,
    "increasedecreaseinothercurrentliabilities": 2000,
    "increasedecreaseinsalesreturnliability": 31000,
    "netcashprovidedbyusedinoperatingactivities": -3908000,
    "proceedsfromdistributionofrestrictedstockunits": 2000,
    "proceedsfromrelatedpartydebt": 4350000,
    "repaymentsofdebt": 2573000,
    "netcashprovidedbyusedinfinancingactivities": 1779000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -2129000,
    "interestpaidnet": 759000,
    "cash": 91000,
    "cashandcashequivalentsatcarryingvalue": 91000,
    "proceedsfromissuanceoflongtermdebt": 4350000,
    "paymentsofdebtissuancecosts": 172000,
    "cashcashequivalentandmarketablesecurities": 91000,
    "workingcapital": 974000000,
    "debtinstrumentfaceamount": 172000,
    "debtinstrumentcarryingamount": 4350000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 2.52,
    "allocatedsharebasedcompensationexpense": 27000,
    "propertyplantandequipmentusefullife": "P7Y",
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 207000,
    "minimumnetsalesreachingdescription": "one-time $12.5 million sales-based milestone payment when worldwide Oxaydo net sales reach $150 million in a calendar year.",
    "contractbalanceandperformanceobligationsdescription": "The Company's reported contract assets and contract liability balances under the license and collaboration agreements at either December 31, 2018 or 2017 were $0.",
    "propertyplantandequipmentgross": 70000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1906000,
    "accruedcostsharingexpenses": 237000,
    "otheraccruedliabilitiescurrent": 36000,
    "employeerelatedliabilitiescurrent": 6000,
    "accruedprofessionalfeescurrent": 132000,
    "financedinsurancepremiums": 102000,
    "accruedotherprofessionalfeescurrent": 63000,
    "accrualfortaxesotherthanincometaxescurrent": 7000,
    "otheraccruedtaxescurrent": 13000,
    "debtinstrumentperiodicpaymentprincipal": 2573000,
    "debtinstrumentadditions": 4350000,
    "debtinstrumentunamortizeddiscount": 400000,
    "amortizationofdebtdiscountpremium": 28000,
    "writeoffofdeferreddebtdiscountnet": 4000,
    "amortizationexpenseofdebtinstrumentissuancecosts": 13000,
    "writeoffofdeferreddebtissuancecost": 1000,
    "longtermdebt": 4224000,
    "interestexpensetermloanone": 194000,
    "interestexpenserelatedparty": 110000,
    "interestexpensedebtdiscount": 74000,
    "debtrelatedcommitmentfeesanddebtissuancecosts": 231000,
    "interestexpensefinanceinsurancepolicy": 4000,
    "interestexpensedebt": 395000,
    "debtinstrumentmaturitydate": "2020-01-02",
    "debtinstrumentfeeamount": 50000,
    "debtconsultingplacementfee": 100000,
    "classofwarrantorrightoutstanding": 60000,
    "classofwarrantorrightexpirationdate": "December 27, 2020",
    "debtinstrumentperiodicpayment": 260000,
    "debtinstrumentinterestrateeffectivepercentage": 0.1016,
    "debtinstrumentdescriptionofvariableratebasis": "at prime plus 2.0%",
    "warrantsnotsettleableincashfairvaluedisclosure": 495000,
    "maximumbasiccontributionpercentageperemployeeonannualearnings": 0.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1842000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 163000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.59,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.15,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 42.75,
    "classofwarrantorrightterm": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 232000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 3000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1328000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 0.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 459000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 759000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 459000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 8000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 0.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 0.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.028,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentotherthanoptionsdistributedinperiod": 262000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 552000,
    "deferredcompensationarrangementwithindividualrecordedliability": 11000,
    "sharebasedcompensationnonemployeeservicestransactioncashsettlementpercentage": 0.4,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -807000,
    "incometaxreconciliationstateandlocalincometaxes": -141000,
    "effectiveincometaxratereconciliationtaxcreditfederalresearchamount": 23000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 22000,
    "incometaxreconciliationotherreconcilingitems": 17000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 932000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 2174000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 862000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1184000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 71000,
    "deferredtaxassetsother": 151000,
    "deferredtaxassetsgross": 4442000,
    "deferredtaxassetsvaluationallowance": 4442000,
    "operatinglosscarryforwards": 171800000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 1000000,
    "operatinglosscarryforwardsexpirationterm": "P20Y",
    "taxcreditcarryforwardamount": 150000,
    "weightedaveragenumberofsharesissuedbasic": 21033000,
    "weightedaveragenumberofsharesrestrictedstock": 113000,
    "earningspersharebasicanddiluted": -0.18,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1842000,
    "litigationsettlementexpense": 2000,
    "accruedcostsharingexpensesclinicalstudies": 237000
  },
  {
    "date": "2017-12-30",
    "symbol": "ACUR",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2017-12-31",
    "documentfiscalyearfocus": 2017,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "ACURA PHARMACEUTICALS, INC",
    "entitycentralindexkey": 786947,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "No",
    "entityfilercategory": "Smaller Reporting Company",
    "tradingsymbol": "ACUR",
    "cashandcashequivalentsatcarryingvalue": 2220000,
    "royaltyreceivable": 13000,
    "prepaidexpenseandotherassetscurrent": 275000,
    "assetscurrent": 2566000,
    "incometaxesreceivablenoncurrent": 135000,
    "propertyplantandequipmentnet": 679000,
    "finitelivedintangibleassetsnet": 1224000,
    "assets": 4604000,
    "accountspayablecurrent": 3000,
    "accruedliabilitiescurrent": 939000,
    "interestpayablecurrent": 700000,
    "otherliabilitiescurrent": 41000,
    "salesreturnsliabilitycurrent": 254000,
    "longtermdebtcurrent": 2694000,
    "liabilitiescurrent": 4631000,
    "liabilities": 4631000,
    "commonstockvalue": 208000,
    "additionalpaidincapitalcommonstock": 380145000,
    "retainedearningsaccumulateddeficit": -380380000,
    "stockholdersequity": -380380000,
    "liabilitiesandstockholdersequity": 4604000,
    "finitelivedintangibleassetsaccumulatedamortization": 776000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 20796000,
    "commonstocksharesoutstanding": 20796000,
    "licenseandservicesrevenue": 2500000,
    "othersalesrevenuenet": 59000,
    "royaltyrevenue": 19000,
    "salesrevenuegoodsnet": 107000,
    "revenues": 2966000,
    "costofsalesexcludinginventorywritedown": 128000,
    "researchanddevelopmentexpense": 3721000,
    "sellinggeneralandadministrativeexpense": 4342000,
    "costsandexpenses": 8191000,
    "operatingincomeloss": -5225000,
    "investmentincomenonoperating": 4000,
    "interestexpense": 596000,
    "nonoperatingincomeexpense": -592000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -5817000,
    "incometaxexpensebenefit": -135000,
    "netincomeloss": -5682000,
    "comprehensiveincomenetoftax": -5682000,
    "earningspersharebasic": -0.36,
    "earningspersharediluted": -0.36,
    "weightedaveragenumberofsharesoutstandingbasic": 15903000,
    "weightedaveragenumberofdilutedsharesoutstanding": 15903000,
    "cashcashequivalentandmarketablesecurities": 2200000,
    "workingcapital": 2100000,
    "lineofcredit": 2700000,
    "allocatedsharebasedcompensationexpense": 139000,
    "propertyplantandequipmentusefullife": "P10Y",
    "concentrationriskpercentage1": 0.1,
    "amortizationofintangibleassets": 208000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 208000,
    "sharesoutstanding": 20796000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 464000,
    "issuanceofcommonstockvalueundermarketofferings": 3911000,
    "issuanceofcommonstocksharesundermarketofferings": 8913000,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": 7000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 49000,
    "inventoryreserveexpense": 32000,
    "inventoryvaluationwrittenofffinishedgoods": 32000,
    "propertyplantandequipmentgross": 2512000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1833000,
    "depreciation": 100000,
    "accruedcostsharingexpenses": 328000,
    "otheraccruedliabilitiescurrent": 36000,
    "employeerelatedliabilitiescurrent": 70000,
    "accruedprofessionalfeescurrent": 149000,
    "accruedotherprofessionalfeescurrent": 326000,
    "accrualfortaxesotherthanincometaxescurrent": 16000,
    "otheraccruedtaxescurrent": 14000,
    "debtinstrumentcarryingamount": 2740000,
    "debtinstrumentperiodicpaymentprincipal": 2760000,
    "debtinstrumentclassificationamount": -2979000,
    "debtinstrumentunamortizeddiscount": 32000,
    "amortizationofdebtdiscountpremium": 66000,
    "debtinstrumentissuancecosts": -14000,
    "amortizationexpenseofdebtinstrumentissuancecosts": 33000,
    "longtermdebt": 2694000,
    "interestexpensedebt": 497000,
    "interestexpensedebtdiscount": 66000,
    "debtrelatedcommitmentfeesanddebtissuancecosts": 33000,
    "debtinstrumentmaturitydate": "2018-12-01",
    "debtinstrumentprepaymentpercentage": 0.01,
    "debtinstrumentperiodicpaymenttermsballoonpaymenttobepaid": 795000,
    "debtinstrumentfeeamount": 50000,
    "debtconsultingplacementfee": 100000,
    "classofwarrantorrightoutstanding": 60000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 7.98,
    "classofwarrantorrightexpirationdate": "December 27, 2020",
    "repaymentsofdebt": 2760000,
    "debtinstrumentperiodicpayment": 260000,
    "debtinstrumentinterestrateeffectivepercentage": 0.1016,
    "warrantsnotsettleableincashfairvaluedisclosure": 495000,
    "maximumbasiccontributionpercentageperemployeeonannualearnings": 0.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1494000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1782000,
    "stockissuedduringperiodsharesstockoptionsexercised": 18000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 12.33,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.45,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.92,
    "stockissuedduringperiodvaluenewissues": 4000000,
    "depreciationandamortization": 87000,
    "provisionforsalesreturns": 49000,
    "sharebasedcompensation": 464000,
    "amortizationoffinancingcostsanddiscounts": 99000,
    "gainlossondispositionofassets": 2000,
    "increasedecreaseinaccountsreceivable": -23000,
    "increasedecreaseincollaborationrevenuereceivable": -79000,
    "increasedecreaseinroyaltyreceivable": 21000,
    "increasedecreaseininventories": -103000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 7000,
    "increasedecreaseinincometaxesreceivable": 135000,
    "increasedecreaseinaccountspayable": -74000,
    "increasedecreaseinaccruedliabilities": 236000,
    "increasedecreaseininterestpayablenet": 141000,
    "increasedecreaseinothercurrentliabilities": 22000,
    "increasedecreaseinsalesreturnliability": 99000,
    "netcashprovidedbyusedinoperatingactivities": -4510000,
    "proceedsfromsaleofpropertyplantandequipment": 103000,
    "proceedsfrommarketofferingofshares": 206000,
    "netcashprovidedbyusedininvestingactivities": 309000,
    "proceedsfromissuanceofcommonstock": 4000000,
    "netcashprovidedbyusedinfinancingactivities": 1240000,
    "cashandcashequivalentsperiodincreasedecrease": -2961000,
    "interestpaidnet": 355000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 185000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 87000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1224000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 14.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 262000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 438000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 238000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 14000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 1.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.018,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentotherthanoptionsdistributedinperiod": 67000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharespurchasedforaward": 3000,
    "deferredcompensationarrangementwithindividualrecordedliability": 41000,
    "sharebasedcompensationnonemployeeservicestransactioncashsettlementpercentage": 0.4,
    "weightedaveragenumberofsharesissuedbasic": 15790000,
    "weightedaveragenumberofsharesrestrictedstock": 113000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1842000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1978000,
    "incometaxreconciliationstateandlocalincometaxes": -203000,
    "incometaxreconciliationtaxcreditsresearch": -105000,
    "effectiveincometaxratereconciliationtaxcreditfederalresearchamount": 70000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 116000,
    "effectiveincometaxratereconciliationtaxcreditfederalalternativeminimumtaxamount": 135000,
    "incometaxreconciliationotherreconcilingitems": -3000,
    "incometaxreconciliationchangeinenactedtaxrate": 26603000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -24570000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 1028000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 1276000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1231000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 66000,
    "deferredtaxassetsother": 203000,
    "deferredtaxassetsgross": 3804000,
    "deferredtaxassetsvaluationallowance": 3804000,
    "operatinglosscarryforwards": 167700000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.35,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 1000000,
    "operatinglosscarryforwardsexpirationterm": "P20Y",
    "operatinglosscarryforwardsexpirationyear": 2037,
    "taxcreditcarryforwardamount": 150000,
    "operatingleasesrentexpensenet": 2000,
    "accruedcostsharingexpensesclinicalstudies": 328000
  },
  {
    "date": "2016-12-30",
    "symbol": "ACUR",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2016-12-31",
    "documentfiscalyearfocus": 2016,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "ACURA PHARMACEUTICALS, INC",
    "entitycentralindexkey": 786947,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Smaller Reporting Company",
    "tradingsymbol": "ACUR",
    "cashandcashequivalentsatcarryingvalue": 2681000,
    "restrictedcashandcashequivalentsatcarryingvalue": 2500000,
    "accountsreceivablenet": 23000,
    "collaborationrevenuereceivable": 79000,
    "royaltyreceivable": 50000,
    "inventorynet": 309000,
    "prepaidexpenseandotherassetscurrent": 268000,
    "assetscurrent": 5910000,
    "propertyplantandequipmentnet": 867000,
    "finitelivedintangibleassetsnet": 1431000,
    "assets": 8208000,
    "accountspayablecurrent": 77000,
    "accruedliabilitiescurrent": 703000,
    "otherliabilitiescurrent": 27000,
    "salesreturnsliabilitycurrent": 304000,
    "longtermdebtcurrent": 2376000,
    "liabilitiescurrent": 3487000,
    "longtermdebtnoncurrent": 2979000,
    "longtermportionofaccruedinterest": 559000,
    "liabilities": 7025000,
    "commonstockvalue": 118000,
    "additionalpaidincapitalcommonstock": 375763000,
    "retainedearningsaccumulateddeficit": -374698000,
    "stockholdersequity": -374698000,
    "liabilitiesandstockholdersequity": 8208000,
    "allowancefordoubtfulaccountsreceivablecurrent": 7000,
    "finitelivedintangibleassetsaccumulatedamortization": 569000,
    "debtinstrumentunamortizeddiscount": 98000,
    "debtinstrumentissuancecost": 47000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 11834000,
    "commonstocksharesoutstanding": 11834000,
    "restrictedcashandinvestments": 2500000,
    "cashcashequivalentandmarketablesecurities": 2700000,
    "workingcapital": 700000,
    "operatingincomeloss": -6557000,
    "netincomeloss": -7388000,
    "debtdefaultlongtermdebtamount": 2500000,
    "concentrationriskpercentage1": 0.24,
    "licenseandservicesrevenue": 3500000,
    "othersalesrevenuenet": 392000,
    "royaltyrevenue": 149000,
    "salesrevenuegoodsnet": 423000,
    "revenues": 4464000,
    "costofsalesexcludinginventorywritedown": 451000,
    "inventorywritedown": 26000,
    "researchanddevelopmentexpense": 4028000,
    "sellinggeneralandadministrativeexpense": 6516000,
    "costsandexpenses": 11021000,
    "investmentincomenonoperating": 60000,
    "interestexpense": 893000,
    "othernonoperatingincomeexpense": 2000,
    "nonoperatingincomeexpense": -831000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -7388000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 65000,
    "comprehensiveincomenetoftax": -7323000,
    "earningspersharebasic": -0.62,
    "earningspersharediluted": -0.62,
    "weightedaveragenumberofsharesoutstandingbasic": 11870000,
    "weightedaveragenumberofdilutedsharesoutstanding": 11870000,
    "propertyplantandequipmentusefullife": "P10Y",
    "allocatedsharebasedcompensationexpense": 444000,
    "weightedaveragenumberofsharesissuedbasic": 11834000,
    "weightedaveragenumberofsharesrestrictedstock": 36000,
    "incrementalcommonsharesattributabletoconversionofcommonstock": 11834000,
    "incrementalcommonsharesattributabletorestrictedstock": 36000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 60000,
    "losscontingencysettlementagreementterms": "Egalet paid us $5.0 million upon signing the Egalet Agreement",
    "revenuerecognitionsalesreturnsreserveforsalesreturns": 304000,
    "professionalandcontractservicesexpense": 200000,
    "newaccountingpronouncementorchangeinaccountingprinciplecumulativeeffectofchangeonequityornetassets1": 162000,
    "assetimpairmentcharges": 82000,
    "researchanddevelopmentarrangementremainingamountothers": 50000,
    "paymentfortermination": 2000000,
    "minimumnetsalesreachingdescription": "one-time $12.5 million milestone payment when worldwide Oxaydo net sales reach $150 million in a calendar year.",
    "retailrelatedinventory": 260000,
    "amortizationofintangibleassets": 207000,
    "inventoryrawmaterialsandsupplies": 98000,
    "inventoryfinishedgoods": 243000,
    "inventorygross": 341000,
    "inventoryvaluationreserves": 32000,
    "sharesoutstanding": 11834000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 65000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 588000,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": 18000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 33000,
    "inventoryreserveexpensefinishedgoods": 26000,
    "inventoryreserveexpense": 96000,
    "inventoryvaluationwrittenofffinishedgoods": -64000,
    "propertyplantandequipmentgross": 2807000,
    "impairmentofpropertyplantandequipmentreserve": -82000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1858000,
    "depreciation": 100000,
    "accruedprofessionalfeescurrent": 232000,
    "otheraccruedliabilitiescurrent": 95000,
    "employeerelatedliabilitiescurrent": 116000,
    "accruedotherprofessionalfeescurrent": 233000,
    "marketingadvertisingandpromotion": 10000,
    "accrualfortaxesotherthanincometaxescurrent": 16000,
    "otheraccruedtaxescurrent": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.024,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P7Y",
    "debtinstrumentcarryingamount": 2979000,
    "debtinstrumentperiodicpaymentprincipal": 2540000,
    "debtinstrumentclassificationamount": -2741000,
    "amortizationofdebtdiscountpremium": 95000,
    "classificationofdebtdiscountpremium": 98000,
    "debtinstrumentissuancecosts": -47000,
    "amortizationexpenseofdebtinstrumentissuancecosts": 50000,
    "classificationofdeferreddebtissuancecosts": 47000,
    "longtermdebt": 2979000,
    "interestexpensedebt": 748000,
    "interestexpensedebtdiscount": 95000,
    "debtrelatedcommitmentfeesanddebtissuancecosts": 50000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 2521000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 2979000,
    "debtinstrumentmaturitydate": "2018-12-01",
    "debtinstrumentprepaymentpercentage": 0.01,
    "debtinstrumentperiodicpaymenttermsballoonpaymenttobepaid": 795000,
    "debtinstrumentfeeamount": 50000,
    "debtconsultingplacementfee": 100000,
    "classofwarrantorrightoutstanding": 60000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 7.98,
    "classofwarrantorrightexpirationdate": "December 27, 2020",
    "repaymentsofdebt": 2540000,
    "debtinstrumentperiodicpayment": 260000,
    "debtinstrumentinterestrateeffectivepercentage": 0.1016,
    "interestpayablecurrent": 559000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 60000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.52,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 199000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1062000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 17.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 91000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 88000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 88000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 1.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentotherthanoptionsdistributedinperiod": 42000,
    "maximumbasiccontributionpercentageperemployeeonannualearnings": 0.8,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharespurchasedforaward": 241000,
    "deferredcompensationarrangementwithindividualrecordedliability": 27000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -2512000,
    "incometaxreconciliationstateandlocalincometaxes": 49000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 159000,
    "incometaxreconciliationotherreconcilingitems": 2000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 2302000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 47192000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 2135000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1200000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 57000,
    "deferredtaxassetsother": 332000,
    "deferredtaxassetsgross": 51036000,
    "deferredtaxassetsvaluationallowance": 51036000,
    "depreciationandamortization": 138000,
    "provisiontoreduceinventorytonetrealizablevalue": 26000,
    "provisionforsalesreturns": 99000,
    "sharebasedcompensation": 588000,
    "amortizationoffinancingcostsanddiscounts": 145000,
    "amortizationofbondpremiuminmarketablesecurities": 31000,
    "marketablesecuritiesgainloss": 2000,
    "gainlossondispositionofassets": -1000,
    "increasedecreaseinaccountsreceivable": -19000,
    "increasedecreaseincollaborationrevenuereceivable": 43000,
    "increasedecreaseinroyaltyreceivable": 45000,
    "increasedecreaseinaccruedinvestmentincomereceivable": -37000,
    "increasedecreaseininventories": 59000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -149000,
    "increasedecreaseinotheroperatingassets": -175000,
    "increasedecreaseinaccountspayable": -33000,
    "increasedecreaseinaccruedliabilities": 139000,
    "increasedecreaseininterestpayablenet": 172000,
    "increasedecreaseinothercurrentliabilities": -1000,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": -5563000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 10873000,
    "paymentstoacquirepropertyplantandequipment": 75000,
    "netcashprovidedbyusedininvestingactivitiescontinuingoperations": 10798000,
    "proceedsfromotherequity": 1000,
    "netcashprovidedbyusedinfinancingactivitiescontinuingoperations": -2539000,
    "cashandcashequivalentsperiodincreasedecrease": 2696000,
    "cashandcashequivalentsandrestrictedcash": 5181000,
    "interestpaid": 576000,
    "federalincometaxexpensebenefitcontinuingoperations": 47200000,
    "operatinglosscarryforwards": 138800000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.34,
    "operatinglosscarryforwardsexpirationyear": 2036,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 2100000,
    "valuationallowancedeferredtaxassetchangeinamount": 5600000,
    "numberoflawsuitsfiled": 150,
    "numberoflawsuitsserved": 50,
    "losscontingencynumberofplaintiffs": 445,
    "operatingleasesrentexpensenet": 25000,
    "descriptionoflessorleasingarrangementsoperatingleases": "March 31, 2017",
    "accruedcostsharingexpensesclinicalstudies": 95000
  }
]